Akebia Therapeutics, Inc. AKBA
- AKB-097 — C3 Glomerulopathy Phase 2
- AKB-097 — IgA Nephropathy Phase 2
- AKB-097 — Lupus Nephritis Phase 2
Factor H (1 companies · 3 programs)
Companies with an active program directed at Factor H.
Companies with an active program directed at Factor H.